No Detail Found!

Effect of celecoxib combined with glucosamine hydrochloride in promoting the functional recovery and decreasing the inflammatory factor levels in patients with knee osteoarthritis

Author(s)
Jin Zhang Sport Medicine, Second Hospital of Shanxi Medical University,Taiyuan Sports,PR China
Ruiyi Ge Sport Medicine, Second Hospital of Shanxi Medical University,Taiyuan Sports,PR China
Ziquan Yang Sport Medicine, Second Hospital of Shanxi Medical University,Taiyuan Sports,PR China
Abstract
To explore the role of celecoxib with glucosamine hydrochloride on functional recovery and reduction of inflammatory factors in patients with knee osteoarthritis. Altogether 128 patients with knee osteoarthritis in the middle and early stage admitted to our hospital from January 2018 to July 2019 were selected and grouped into the control group (CG) (celecoxib tablet therapy) and the combination group (ComG) (celecoxib combined with glucosamine hydrochloride therapy). Blood routine indexes and inflammatory factor levels before and after intervention, Lequesne score, VAS pain and adverse reactions of the two groups of patients before and after intervention were explored. Before intervention, there was no evident difference between the two groups in each index (P>0.05). After intervention, the blood routine index IgM rheumatoid factor, albumin/globulin, erythrocyte sedimentation rate and inflammatory factors TNF-a, IL-6, IL-1ß, hs-CRP levels in the ComG were evidently better than those in the CG, while Lequesne score and VAS pain score were lower than those in the CG (P<0.01). The total incidence of adverse reactions in the ComG was evidently lower than that in the CG. Celecoxib combined with glucosamine hydrochloride is effective in the treatment of knee osteoarthritis and has little adverse reactions.
Publication Details
Page(s) 1277-1282
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S3, Year: 2021

Request the full text from PASTIC

Keywords
Glucosamine hydrochloride, Knee Osteoarthritis, Celecoxib, Inflammatory factor, functional recovery
References
Al-Rashed F,Damien C,Marie L,Thornton CC,Andrea B,Allan K,Dorian OH,Anusha S,Joseph JB,Alex HS,Wheeler-Jones CP,Mason JC .2018 .Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling. Sci. Rep, 8(1) : 6271.
Anwar A,Anwar IJ,Delafontaine P .2015 .Elevation of cardiovascular risk by non-steroidal antiinflammatory drugs. Trends Cardiovasc. Med, 25(8) : 726-35.
Arntz OJ,Pieters BCH,Thurlings RM,Wenink MH,van Lent PLEM,Koenders MI,van De Loo FAJ MI .2018 .Rheumatoid arthritis patients with circulating extracellular vesicles positive for igm rheumatoid factor have higher disease activity. Front. Immunol., 9(3) : 2388.
Bascoul-Colombo C,Garaiova I,Plummer SF,Harwood JL,Caterson B,Hughes CE .2016 .Glucosamine hydrochloride but not chondroitin sulfate prevents cartilage degradation and inflammation induced by interleukin-1alpha in bovine cartilage explants. Cartilage, 7(1) : 70-81.
Benner RW,Shelbourne KD,Bauman SN,Adam N,Tinker G .2019 .Knee osteoarthritis: Alternative range of motion treatment. Orthop. Clin. North Am., 50(4) : 425-432.
Bhathal A,Meredith S,Christopher L,Grace F L .2017 .Glucosamine and chondroitin use in canines for osteoarthritis: A review. Open Vet. , 7(1) : 36-49.
Bruyere O,Altman RD,Reginster JY .2016 .Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum, 45(4 Suppl)) : S12-7.
Charlesworth J,Fitzpatrick J,Nirmala K Panagodage P and John O J .2019 .Osteoarthritis: A systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet Disord, 20(1) : 151.
Hussain SM,Cicuttini FM,Alyousef B,Wang Y .2018 .Female hormonal factors and osteoarthritis of the knee, hip and hand: A narrative review. Climacteric, 21(2) : 132-139.
Kim J,Seung-Woo H,Seonghan K,Daejin K,Hur DY,Dong-Hoon J,Bomi K,Yeong SK K .2018 .Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes. Int. J. Oncol., 52(2) : 613-620.
Kosloski MP,Sandra G,Susanne XW,Jia L,Ralf L,Jeroen KM,Wei L,Sandeep D L .2016 .Pharmacokinetics and tolerability of a dual variable domain immunoglobulin ABT-981 against IL-1alpha and IL1beta in healthy subjects and patients with osteoarthritis of the knee. J. Clin. Pharmacol, 56(12) : 1582-1590.
Lespasio MJ,Piuzzi NS,Husni ME,Muschler GF,Guarino AJ,Mont MA .2017 .Knee osteoarthritis: A primer. , 21 : 16-183.
Madry H,Elizaveta K,Vincenzo C,Giuseppe MP,Steinwachs M,Romain S,Massimo B,Lars E,Giuseppe F,Peter A F .2016 .Early osteoarthritis of the knee. Knee Surg Sports Traumatol, 24(6) : 1753-1762.
McCarty MF,O'Keefe JH,DiNicolantonio JJ .2019 .Glucosamine for the treatment of osteoarthritis: The time has come for higher-dose trials. J. Diet. Suppl., 16(2) : 179-192.
Messina OD,Wilman MV,Vidal LFN .2019 .Nutrition, osteoarthritis and cartilage metabolism. Aging. Clin. Exp. Res., 31(6) : 807-813.
Moore N,Mai D,Sinem EG,Patrick B,Cecile D B .2019 .Pharmacoepidemiology of non-steroidal anti-inflammatory drugs. Therapie, 74(2) : 271-277.
Navarro SL,Marta H,Helena M,Yuzheng Z,Jon L,Edward Lo,Timothy WR,Johanna WL,Paul DL .2020 .Differences in serum biomarkers between combined glucosamine and chondroitin versus celecoxib in a randomized, doubleblind trial in osteoarthritis patients. Anti-Inflamm. Antiallergy Agents Med. Chem, 19(2) : 190-201.
Parisi S,Maria CD,Marta P,Richard B,Angela L,Clara LP,Enrico F LP .2019 .Ultrasound-guided intraarticular injection: Efficacy of hyaluronic acid compared to glucocorticoid in the treatment of knee osteoarthritis. Minerva. Med, 110(6) : 515-523.
Puigdellivol J,Berenger CC,Fernandez MAP,Millan JMC,Christian CV,Ines GG,Julio MP,Borja RN,Francisco JG,Figuerola FXC,Hernandez MEA .2019 .Effectiveness of a dietary supplement containing hydrolyzed collagen, chondroitin sulfate and glucosamine in pain reduction and functional capacity in osteoarthritis patients. J. Diet. Suppl., 16(4) : 379-389.
Puljak L,Marin A,Davorka V,Filipa M,Utrobicic A,Peter T A .2017 .Celecoxib for osteoarthritis. Cochrane Database Syst. Rev., 5 : CD009865.
Radi ZA,Khan KN .2019 .Cardio-renal safety of non-steroidal anti-inflammatory drugs. J. Toxicol. Sci., 44(6) : 373-391.
Ricciotti E,Cecilia C,Soon YT,Briggs WTE,James AW,Dania M,Seth DR,Meng H,Xuanwen Li,Nicholas FL,Jeffrey AS,Elizabeth WK,Aalim MW,Julian LG,FitzGerald GA LG .2018 .Cyclooxygenase-2, asymmetric dimethylarginine and the cardiovascular hazard from nonsteroidal anti-inflammatory drugs. Circulation, 138(21) : 2367-2378.
Sterzi S,Giordani L,Michelangelo M,Emanuela L,Giovanni M,Claudia S,Stefano M,Leonardo P,Marco B,Ilaria P,Concetta L,Federica B,Calogero F B .2016 .The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: A randomized, double-blind, placebocontrolled study. Eur. J. Phys. Rehabil. Med, 52(3) : 321-330.
Taylor N .2018 .Nonsurgical management of osteoarthritis knee pain in the older adult: An update. Rheum. Dis. Clin. North Am., 44(3) : 513-524.
van Midwoud PM,Marjan S,Wim EH,Leo GJ,Harrie W GJ .2018 .In vivo pharmacokinetics of celecoxib loaded endcapped PCLA-PEG-PCLA thermogels in rats after subcutaneous administration. Eur. J. Pharm. Biopharm., 131 : 170-177.
Zhao Y,Yuhua Li,Qu Ruize,Xiaomin C,Wenhan W,Cheng Q,Ben L,Xin P,Liang L,Krasimir V,John H,Shuli D,Weiwei Li D .2019 .Cortistatin binds to TNF-alpha receptors and protects against osteoarthritis. EBio Medicine, 41 : 556-570.
0

Citations

0

Downloads

13

Views